Mark Douglas Smith
Director · 5 filings · Latest: Aug 31, 2026
Jazz Pharmaceuticals plc
Phreesia, Inc.
Teladoc Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Smith Mark Douglas | — | Aug 31, 2026 | Proposed Sale | $244.54 | 3,507 | $857.6K | — | |
JAZZ | Mark Douglas Smith | Director | Jun 15, 2026 | Sale | $230.55 | 1,157 | $266.7K | 9,680 | |
JAZZ | MARK D SMITH | — | Jun 15, 2026 | Proposed Sale | $230.55 | 1,157 | $266.7K | — | |
JAZZ | Smith Mark Douglas | — | Aug 8, 2025 | Proposed Sale | $112.00 | 3,731 | $417.9K | — | |
PHR | Smith Mark Douglas | — | Jul 2, 2025 | Proposed Sale | $29.00 | 7,000 | $203.0K | — |